TGA Complaint Outcomes: Pharmacare Laboratories Ease-a-cold products

On 5 July 2018 I complained to the TGA about the promotion of Pharmacare Laboratories Ease-a-cold products (TGA reference AL-B81GN1V3/2018).

The TGA have now published the outcome of this complaint noting that in all cases that a breach was found, compliance was achieved by formal contact without any other action required.

The attached document contains screenshots (taken today) of promotion from the sites complained about. I argue they show that:

  1. Compliance has not been achieved in any of these sites. The name of the product, “Ease-a-cold”, the claims, “Scientifically/Specifically formulated to help shorten a cold”  and “reduce the severity of 31 different symptoms of a cold on your daily life”, are misleading, deceptive and lack evidence to substantiate them.
  2. The TGA has not addressed additional code breaches that were alleged, e.g. 4(1)(b), & 4(2)(a);
  3. The rationale for some breaches suggested by the TGA are unclear, e.g. 42DL(12), 22(5)and 42DLB(4);
  4. It is also unclear why the TGA found no Code breach for the Chemist Warehouse and Epharmacy web sites (illustrated).
  5. Public Summary Documents of several Ease‐a‐cold products continue to make claims that appear to breach the Code, e.g. 194706, 232713.

I have requested a meeting with the TGA to discuss these concerns.

linkedinrsslinkedinrssby feather

About Dr Ken Harvey

Public Health Physician, Medical activitist
This entry was posted in Advertising, Pharmaceutical Promotion and tagged , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.